Showing results (1341-1350 of 3,636) with videos related to
Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|March 27, 2007
Fertility and pregnancy after breast cancerAlison Louise JonesBreast (Edinburgh, Scotland)|March 27, 2007
Psychological management of pregnancy-related breast cancerRosanna Zanetti-Dällenbach, Sibil Tschudin, Olav Lapaire, et al.Breast (Edinburgh, Scotland)|February 9, 2007
Eleven years of experience reveals that fine-needle aspiration cytology is still a useful method for preoperative diagnosis of breast carcinomaQingqing He, Xihong Fan, Tinggui Yuan, et al.Breast (Edinburgh, Scotland)|February 13, 2007
Quantification of circulating tumour cells for the monitoring of adjuvant therapy in breast cancer: an increase in cell number at completion of therapy is a predictor of early relapseKurt Lobodasch, Frank Fröhlich, Matthias Rengsberger, et al.Breast (Edinburgh, Scotland)|February 3, 2007
Quality of breast imaging reports falls short of recommended standardsNehmat Houssami, John Boyages, Kirsty Stuart, et al.Breast (Edinburgh, Scotland)|January 24, 2007
The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial)Penelope Hopwood, Joanne Haviland, Judith Mills, et al.Breast (Edinburgh, Scotland)|June 13, 2006
Rural-urban differences in the presentation, management and survival of breast cancer in Western AustraliaK J Mitchell, L Fritschi, A Reid, et al.Breast (Edinburgh, Scotland)|December 13, 2006
A pilot study to evaluate the impact of involving breast cancer patients in the multidisciplinary discussion of their disease and treatment planE T Choy, A Chiu, P Butow, et al.Breast (Edinburgh, Scotland)|November 14, 2006
Atypical presentations of screen-detected DCIS Implications for pre-operative assessment and surgical interventionGelareh Farshid, Peter Downey, P Grantley GillBreast (Edinburgh, Scotland)|November 14, 2006
The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapiesKalliopi P Siziopikou, Melody CobleighPageof 364